Darwin Advisors, LLC Novartis Ag Transaction History
Darwin Advisors, LLC
- $291 Million
- Q3 2025
A detailed history of Darwin Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Darwin Advisors, LLC holds 112 shares of NVS stock, worth $13,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112
Previous 112
-0.0%
Holding current value
$13,864
Previous $13,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.32 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.29 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.12 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$936 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$882 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $266B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...